Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000228501 | SCV000291762 | uncertain significance | Charcot-Marie-Tooth disease type 4 | 2020-01-06 | criteria provided, single submitter | clinical testing | This sequence change replaces valine with alanine at codon 525 of the PRX protein (p.Val525Ala). The valine residue is weakly conserved and there is a small physicochemical difference between valine and alanine. This variant is present in population databases (rs149715830, ExAC 0.2%). This variant has been reported in 3 individuals affected with peripheral neuropathy (PMID: 24627108, 26392352). ClinVar contains an entry for this variant (Variation ID: 242179). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The alanine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, this variant has uncertain impact on PRX function. The available evidence is currently insufficient to determine its role in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Illumina Clinical Services Laboratory, |
RCV001094584 | SCV000413235 | uncertain significance | Charcot-Marie-Tooth disease, demyelinating, type 4F | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Gene |
RCV000431721 | SCV000514286 | likely benign | not specified | 2017-09-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
EGL Genetic Diagnostics, |
RCV000658836 | SCV000703932 | uncertain significance | not provided | 2018-05-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000658836 | SCV000780632 | uncertain significance | not provided | 2019-10-01 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV000789549 | SCV001335853 | likely benign | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Athena Diagnostics Inc | RCV000431721 | SCV001475998 | benign | not specified | 2020-06-24 | criteria provided, single submitter | clinical testing | |
Inherited Neuropathy Consortium | RCV000789549 | SCV000928905 | uncertain significance | Charcot-Marie-Tooth disease | no assertion criteria provided | literature only |